Based on recent research and analysis of the Chinese surgical robot market, as well as studies and evaluations of related companies in the industry, the globally renowned growth consulting firm Frost & Sullivan (Frost & Sullivan, abbreviated as: Frost & Sullivan) awarded Beijing Xianwei Medical Technology Co., Ltd. the 'China Ophthalmic Surgical Robot Innovation Award'. Mr. Wang Chenhui, Managing Partner and Executive Vice President of Frost & Sullivan Greater China, presented the award to Ms. Guo Shasha, Operations Manager of Beijing Xianwei Medical Technology Co., Ltd.
Frost & Sullivan awarded Beijing Xianwei Medical Technology Co., Ltd.
‘China Ophthalmic Surgical Robot Innovation Award’
Mr. Wang Chenhui presented the award to Ms. Guo Shasha, Operations Manager of Xianwei Medical
Beijing Xianwei Medical Technology Co., Ltd. develops innovative ophthalmic surgical robots to provide better ophthalmic solutions for patients
Beijing Xianwei Medical Technology Co., Ltd. (abbreviated as 'Xianwei Medical') was established in 2022, focusing on the research and development of innovative equipment and devices in various fields such as ophthalmic surgical robots and dry eye treatment. Currently, Xianwei Medical's outstanding technical strength and market potential have been recognized by institutions such as Danlu Capital and Shuimu Oriental Medical Robotics, receiving tens of millions in angel financing to assist the company in finalizing the product design and sending for inspection of the third-generation ophthalmic surgical robot, and will also apply for medical device registration certificates for other ongoing product pipelines including dry eye treatment equipment simultaneously.
Beijing Xianwei Medical Technology Co., Ltd. solidifies theoretical research and accumulates profound technical research experience
The core R&D team of Xianwei Medical has been deeply involved in the field of ophthalmic robots for over a decade, accumulating profound technical research experience. They have published over 30 high-level SCI and EI papers in domestic and international journals and conferences, applied for more than 20 invention patents related to ophthalmic robots and intelligent ophthalmic devices, and have obtained 15 authorized patents. The team's research results were included in the 'Handbook of Robotic and Image- Guided Surgery' (Elsevier Publishing) compiled by authoritative experts on surgical robots worldwide in 2020.
Beijing Xianwei Medical Technology Co., Ltd.'s ophthalmic surgical robot technology is leading domestically and synchronized with advanced foreign levels
Xianwei Medical's ophthalmic surgical robots have been iterated to the third generation, maintaining technical indicators synchronized with the world's leading level, and at the same time, it has significant technical and experience advantages in intelligent perception, control, precision processing, and manufacturing at the end of robot devices. Xianwei Medical's ophthalmic robots integrate advanced robot mechanisms, precision drive technology, artificial intelligence algorithms, and advanced control technologies, breaking through various physiological limits of the human body, endowing ophthalmic robots with the ability to perform micron-level surgeries, expanding the application fields of ophthalmic surgery, reducing the difficulty of ophthalmic surgery, helping young and middle-aged ophthalmologists shorten their training cycles, and assisting surgical experts extend their professional influence.
About the Frost & Sullivan Life Sciences New Investment Summit Forum
The 2023 Frost & Sullivan Life Sciences New Investment Summit Forum was held on September 27-28, with the theme of 'New Directions to the Future & Forge Ahead', gathering more than 30 industry leaders, life science enterprises, investment institutions, and professional service agencies, focusing on new opportunities for life science investment and financing, and jointly discussing the capital and industrial forces for enterprises to navigate through cycles.
About the Frost & Sullivan China Innovation Award
The Frost & Sullivan China Innovation Award is an acknowledgment of outstanding performance and achievements in technological innovation, market potential, customer service, brand, etc. by enterprises. The Frost & Sullivan team nominated a group of competitive outstanding enterprises to the independent judging panel through methods such as in-depth interviews, industry analysis, and secondary research. An independent judging panel composed of third-party investment and financing experts, financial experts, bankers, and well-known listed entrepreneurs conducted a strict review of the enterprises nominated by the Frost & Sullivan team, and decided to award the 'China Ophthalmic Surgical Robot Innovation Award' to Beijing Xianwei Medical Technology Co., Ltd.
